Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × mitazalimab × Gastrointestinal × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Fluorouracil 611 Oxaliplatin 575 Gemcitabine 488 Capecitabine 445 Leucovorin 423 Irinotecan 387 Bevacizumab 326 Cisplatin 318 Radiotherapy 244 Cetuximab 214 Sorafenib 167 Docetaxel 148 pembrolizumab 147 Paclitaxel 139 Nivolumab 124 Albumin-Bound Paclitaxel 106 130-nm albumin-bound paclitaxel 106 Folfox protocol 100 Panitumumab 94 Erlotinib Hydrochloride 94 Surgical Procedures, Operative 86 regorafenib 82 S 1 (combination) 81 Drug Therapy 80 Radiation 69 Carboplatin 65 Colonoscopy 64 Neoadjuvant Therapy 63 Radiosurgery 62 Surveys and Questionnaires 60

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05650918 2023-10-12

REACtiVe-2

Erasmus Medical Center

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡